menu
    • menu

    Company profile for Ocugen

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Ocugen, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing transformative therapies to treat the whole eye. Our Phase 3 small molecule drug candidate for ocular Graft Versus Host Disease (oGVHD), if approved, will be the first and only treatment for this orphan disease. Our breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases wi...
    Ocugen, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing transformative therapies to treat the whole eye. Our Phase 3 small molecule drug candidate for ocular Graft Versus Host Disease (oGVHD), if approved, will be the first and only treatment for this orphan disease. Our breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with one drug – “one to many”. And our novel biologic product candidate aims to offer better therapy to patients with underserved diseases such as wet age-related macular degeneration.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    OcugenUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    5 Great Valley Parkway, Suite 160 Malvern, PA 19355
    Telephone
    Telephone
    484.328.4701
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://ocugen.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ocugen
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Ocugen

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ocugen CEO Presents At Noblecon21 Equity Conference
    Ocugen CEO Presents At Noblecon21 Equity Conference

    20 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/20/3191777/0/en/Ocugen-CEO-to-Present-at-NobleCon21-Noble-Capital-Markets-Twenty-First-Annual-Emerging-Growth-Equity-Conference.html

    GLOBENEWSWIRE
    20 Nov 2025
    Share Share
    Ocugen Updates Business With Q3 2025 Financial Results
    Ocugen Updates Business With Q3 2025 Financial Results

    05 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/05/3181230/0/en/Ocugen-Provides-Business-Update-with-Third-Quarter-2025-Financial-Results.html

    GLOBENEWSWIRE
    05 Nov 2025
    Share Share
    Ocugen Webcast To Review Business Updates And Q3 2025 Finances
    Ocugen Webcast To Review Business Updates And Q3 2025 Finances

    23 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/23/3171931/0/en/Ocugen-to-Host-Webcast-on-Wednesday-November-5-at-8-30-A-M-ET-to-Discuss-Business-Updates-and-Third-Quarter-2025-Financial-Results.html

    GLOBENEWSWIRE
    23 Oct 2025
    Share Share
    Ocugen to Present at Industry and Investor Conferences in October
    Ocugen to Present at Industry and Investor Conferences in October

    02 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/02/3160277/0/en/Ocugen-to-Present-at-Industry-and-Investor-Conferences-in-October-2025.html

    GLOBENEWSWIRE
    02 Oct 2025
    Share Share
    Carisma’s Lifeline Disappears as Reverse Merger Plans Break Down
    Carisma’s Lifeline Disappears as Reverse Merger Plans Break Down

    18 Sep 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/carismas-lifeline-dissipates-reverse-merger-plans-fall-through-moderna-cuts-ties

    FIERCE BIOTECH
    18 Sep 2025
    Share Share
    Ocugen & Kwangdong Finalize OCU400 Gene Therapy License in Korea
    Ocugen & Kwangdong Finalize OCU400 Gene Therapy License in Korea

    15 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/15/3149790/0/en/Ocugen-Inc-and-Kwangdong-Pharmaceutical-Co-Ltd-Complete-License-Agreement-of-OCU400-Modifier-Gene-Therapy-for-Retinitis-Pigmentosa-in-Korea.html

    GLOBENEWSWIRE
    15 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search